Manufacturer record

Vaidban Ayurved Bhawan: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

1 batch manufactured by Vaidban Ayurved Bhawan (Haryana) was declared Not of Standard Quality in December 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: VBX-044, X-Plus Gold (exp May 2028). RDTL, Chandigarh (CDSCO lab) found it not of standard quality: The sample does not conform to claim as per Patent and Proprietary in respect to The Test of Tadalafil. Listed in the December 2025 alert.

Records by type

1 record linked to Vaidban Ayurved Bhawan in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
1Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Dec 2025 to Dec 2025

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

1
NSQ batches since 2025
1
Products affected
Other
Most common failure
Dec 2025
Latest alert

Flagged batches per year

2025 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
X-Plus Gold Batch VBX-044Mfg Jun 2025 · Exp May 2028 The sample does not conform to claim as per Patent and Proprietary in respect to The Test of TadalafilOther RDTL, ChandigarhCDSCO lab Dec 2025

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.